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Abstract
The Effects of Obesity, Chronic Stress, and Exercise on Pancreatic Health
Abigail L. Tice
Obesity is concomitant with hyperglycemic conditions, increased proinflammatory
cytokines, and increased oxidative stress. Under hyperglycemia, thioredoxin interacting protein
(TXNIP) is increased and causes increased oxidative stress and pancreatic b-cell apoptosis.
Chronic stress is associated with increased glucocorticoid levels and a proinflammatory
environment. The purpose of this study was to examine the effects of obesity, chronic stress, and
exercise on pancreatic health.
Lean Zucker Rats (LZRs) and Obese Zucker Rats (OZRs) were randomly assigned to
four groups: 1) sedentary controls (C: n=8 per); 2) unpredictable chronic mild stress (UCMS) (S:
n=8); 3) exercise (E: n=8); and 4) combined UCMS and exercise (ExS: n=8). Exercise rats
underwent 8 weeks of treadmill running for 60 minutes. Stress rats were subjected to UCMS that
included cage tilt, no bedding, damp bedding, bath, social stress, and altered light-dark cycles for
8 hours a day, 5 days a week for 8 weeks. Pancreas tissue was obtained from rats around 20
weeks of age. Total pancreatic TXNIP protein was quantified, including total pancreatic cytokine
expression for IL-1b, TNF-a, IL-4, and IL-10. Using immunohistochemistry, b-cell and a-cell
counting, islet area measurements, and b-cell to a-cell ratio were examined. TUNEL staining, to
determine apoptosis, was examined in pancreatic lysates.
OZRs had higher insulin, glucose, and body mass compared to LZRs, as wells as higher
b-cell and a-cell number and islet area (p<0.05). TXNIP in pancreas had an increasing trend in
OZR-C compared to LZR-C (p=0.10); TNF-a and IL-4 were higher in OZR-C compared to
LZR-C (p<0.05). Little to no differences in morphology or TXNIP in either genotype of stressed
animal. OZR-S had lower TNF-a, IL-4, and IL-6 when compared to OZR-C (p<0.05). Islet area
and a-cell numbers were lower with exercise in obese animals, while b-cell to a-cell ratio was
higher (p<0.05). TXNIP was not different, but IL-4 and IL-6 were lower in OZR-EX compared
to OZR-C (p<0.05). b-cell and a-ell numbers and islet area were higher in LZR-EXS compared
to LZR-S (p<0.05), but no differences were seen in the obese model of stress and exercise.
TXNIP was lower in LZR-EXS compared to LZR-S (p<0.05), and TXNIP trended to decrease in
OZR-EXS compared to OZR-S (p=0.10). No differences were observed in cytokines in these
groups. No differences were observed in any groups with apoptosis.
In a model of obesity and metabolic syndrome, the pancreas appeared to be stimulated to
grow as indicated by greater numbers of β- and α-cells and larger islets even in the presence of
slightly higher pancreatic TXNIP and TNF-α. Obesity resulted in an increased level of
inflammation and reduced antioxidant potential within the pancreas as indicated by significantly
higher TXNIP, IL-1b, and TNF-a. Eight weeks of treadmill running reversed this effect.
Exercise training was also able to reduced TXNIP within the pancreas as a result of stress.
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE
Metabolic Syndrome, which affects approximately 23 percent of adults in the United
States, is comprised of a cluster of risk factors that can lead to many chronic diseases, including
cardiovascular diseases, cancer, and diabetes1,2,3. The criteria for the Metabolic Syndrome
includes increased waist circumference (obesity), hypertension, high circulating triglycerides,
low high-density lipoprotein-cholesterol (HDL-C), and high fasting glucose.2 The risk factors for
Metabolic Syndrome are similar to risk factors related to the development of type 2 diabetes
(T2D), such as obesity, high circulating triglycerides, and high fasting glucose, and the condition
often leads to insulin resistance and hyperinsulinemia.4,5 There are various modifiable risk
factors that can lead to insulin resistance, including physical inactivity, poor nutrition, obesity,
and stress.1 Obesity is an epidemic affecting nearly one-third of the adult population in the US,
and it is proposed that by 2030, there will be 65 million more obese adults in the US.6,7 Obesity
is the accumulation of excess adipose tissue, an active endocrine tissue, which is a major storage
site for triglycerides, and a major site of pro-inflammatory cytokine production.7,8 Initially,
obesity and a high fat diet is associated with an increase in pancreatic islet mass due to
hypertrophy of the b-cells and the a-cells to compensate for the hyperglycemic state caused by
increased levels of circulating free-fatty acids (FFA).9 Chronically high levels of circulating FFA
are associated fatty acid and ceramide accumulation in peripheral tissues such as the liver and
skeletal muscle which can result in insulin resistance and hyperinsulinemia, a process known as
lipid toxicity.9 It can also result in b-cell dysfunction and eventual decreased insulin secretion, as
a result of an interference with the insulin peptide folding causing an impairment of proper
insulin processing.9 Obesity-induced adipocyte hypertrophy leads to altered visceral adipose
tissue (VAT) homeostasis which causes an elevation of circulating proinflammatory cytokines,
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such as IL-6 and TNF-a, through the proliferation of proinflammatory cells within the VAT.10
These proinflammatory cytokines are also seen to promote insulin resistance and place the body
in a proinflammatory state by negatively affecting the insulin cascade.7,8,11,12,13
Stress, another modifiable risk factor for obesity, can lead to the hypersecretion of
glucocorticoids (GCs) and proinflammatory cytokines, such as IL6 and TNF-a.14 An
upregulation of proinflammatory cytokines can lead to insulin resistance and an increased risk
for the development of T2D.15 When the body senses stress, the hypothalamus-pituitary-adrenal
(HPA) axis and sympathetic nervous system (SNS) are activated to release GCs and
catecholamines (norepinephrine and epinephrine), respectively.16 In the presence of chronic
stress, the HPA axis is subject to dysregulation, which in turn dysregulates inflammation with an
associated increase in proinflammatory cytokines. Immune cells become desensitized to GCs that
normally terminate an immune response, inducing a proinflammatory environment.17
Chronically elevated levels of circulating GCs promote increased adiposity and increase stress on
pancreatic islet cell function.9 Upregulated GC exposure over time leads to increased insulin
secretion and induces an increase in caloric intake, preference for calorically-dense foods, and
circulating FFAs, promoting insulin resistance.9 The excessive secretion of GCs that is seen with
chronic stress can lead to depression.14 Depression has been associated with poor health
behaviors, including physical inactivity, smoking, and excessive caloric intake which can lead to
obesity.15 Therefore, the co-morbidities are often linked in humans.
Physical inactivity is another modifiable risk factor of T2D, yet 80 percent of the US
adult population does not meet recommendations for physical activity.18 A single bout of
moderately intense exercise is associated with increased insulin sensitivity for 12-48 hours post
exercise bout.19 Insulin sensitivity and b-cell function homeostasis are maintained through the
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balance of b-cell replication, neogenesis, and apoptosis, and regular exercise stimulates b-cell
neogenesis. Chronic, daily, physical activity not only improves insulin sensitivity and action, but
also works to improve GLUT4 translocation in skeletal muscle. This in turn reduces insulin
requirements and improves peripheral insulin action. Regular physical activity preserves b-cell
mass through the prevention of b-cell exhaustion that is seen through overuse in T2D. Acute
exercise increases the release of GCs through the stimulation of the HPA axis, but with regular
exercise, HPA axis activity can be normal or even reduced at rest.20 In addition, regular exercise
lowers elevated GCs, mainly cortisol, brought about by chronic stress, therefore increasing
insulin sensitivity and reducing insulin resistance.21
The thioredoxin system is a key component of the cellular anti-oxidant mechanism.22
Thioredoxin-interacting protein (TXNIP), a proapoptotic factor stimulated by hyperglycemia,
acts as an inhibitor of thioredoxin (Trx), interfering with the anti-oxidant response and promoting
oxidative stress.22,23,24,25 Hyperglycemia enhances the interaction between TXNIP and Trx, and
TXNIP is essential for glucose toxicity-induced b-cell apoptosis. 22,23,24 TNXIP interferes with
Trx through a variety of pathways, including mitochondrial interaction, cytoplasmic interference,
and nuclear mechanisms.22,23,24,25,26 Within the mitochondria, TXNIP binds to Trx2, releasing
apoptosis signal regulating kinase-1 (ASK1) from its inhibited state, increasing the release of
Cytochrome C (Cyt-C) and cleaved caspase-3, which leads to b-cell apoptosis.23,25,26 The
TXNIP/Trx interaction in the cytoplasm causes the anti-oxidative mechanisms of Trx1 to be
inhibited, increasing oxidative stress and leading to b-cell apoptosis.25,26. Through increased
TXNIP expression, insulin transcription and b-cell function are reduced through the increased
expression of microRNAs that interfere with the expression of target genes.24,25 Along with these
increases in apoptosis, increased TXNIP expression also leads to the activation of the nod-like
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receptor protein 3 (NLRP3) inflammasome, a major producer of IL-1b, a proinflammatory
cytokine associated with insulin resistance.22,27,28 ER stress induces increased TXNIP expression
through unfolded protein response pathways IRE1-a and PERK, and therefore ER stress
regulated NLRP3 production of IL-1b through TXNIP pathway, increasing the proinflammatory
environment in the pancreas and other parts of the body.28

PURPOSE AND SPECIFIC AIMS
The purpose of this study was to assess the effects of obesity, chronic stress and exercise
training on pancreatic health in a model of metabolic syndrome. We hypothesized that obesity
would cause a decrease in pancreatic b-cell number and islet area because of an increase in
TXNIP, the proinflammatory environment, and overall apoptosis-related proteins in the
pancreas. We also hypothesized that stress would further increase and exercise training decrease
these effects, through altered TXNIP and pro- and anti-inflammatory cytokines within the
pancreas.

Specific Aim 1.1: To determine the effects of obesity on pancreatic morphology
Hypothesis 1. Obesity alone (OZR-C) will decrease the number of pancreatic b-cells, the b-cell
to a-cell ratio, and islet area when compared with lean animals (LZR-C).

Specific Aim 1.2: To determine the effects of stress alone and in combination with obesity on
pancreatic morphology
Hypothesis 1. Eight weeks of UCMS (LZR-S) will decrease the number of pancreatic b-cells, the
b-cell to a-cell ratio, and islet area when compared with lean animals (LZR-C).
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Hypothesis 2. Eight weeks of UCMS in combination with obesity (OZR-S) will augment the
obesity-related decreases in the number of pancreatic b-cells, the b-cell to a-cell ratio, and islet
area when compared with obese (OZR-C) animals.

Specific Aim 1.3: To determine the effects of exercise training on the obesity and stress related
changes to pancreatic morphology.
Hypothesis 1. Eight weeks of treadmill running in combination with obesity (OZR-EX) will
attenuate the obesity-related decreases in pancreatic b-cell number, the b-cell to a-cell ratio, and
islet area compared with obese animals (OZR-C).
Hypothesis 2. Eight weeks of treadmill running in combination with eight weeks of UCMS
(LZR-EXS) will attenuate the stress-related decreases in pancreatic b-cell number, the b-cell to
a-cell ratio, and islet area compared with lean stressed animals (LZR-S).
Hypothesis 3. Eight weeks of treadmill running will attenuate the combined effects of obesity
and UCMS (OZR-EXS) on pancreatic decreases in b-cell number, the b-cell to a-cell ratio, and
islet area compared with obsess stressed animals (OZR-S).

Specific Aim 2.1: To determine the effects of obesity on the pancreatic pro-inflammatory
environment and level of apoptosis
Hypothesis 1. Obesity alone (OZR-C) will result in an increase in pancreatic TXNIP, proinflammatory cytokines (e.g., IL-1β, IL-6, and TNFα) and apoptosis and a decrease in ant—
inflammatory cytokines (IL-4 and IL-10) compared with lean animals (LZR-C).
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Specific Aim 2.2: To determine the effects of stress alone and in combination with obesity on
the pancreatic pro-inflammatory environment and level of apoptosis
Hypothesis 1. Eight weeks of UCMS (LZR-S) will result in an increase in pancreatic TXNIP,
pro-inflammatory cytokines (e.g., IL-1β, IL-6, and TNFα) and apoptosis and a decrease in antiinflammatory cytokines (IL-4 and IL-10) compared with lean animals (LZR-C).
Hypothesis 2. Eight weeks of UCMS in combination with obesity (OZR-S) will augment the
obesity-related increase in pancreatic TXNIP, pro-inflammatory cytokines (e.g., IL-1β, IL-6, and
TNFα) and apoptosis and a decrease in anti-inflammatory cytokines (IL-4 and IL-10) compared
with obese animals (OZR-C).

Specific Aim 2.3: To determine the effects of exercise training on the obesity and stress related
changes to the pancreatic pro-inflammatory environment and level of apoptosis
Hypothesis 1. Eight weeks of treadmill running in combination with obesity (OZR-EX) will
attenuate the obesity-related increase in pancreatic TXNIP, pro-inflammatory cytokines (e.g., IL1β, IL-6, and TNFα) and apoptosis and a decrease in anti-inflammatory cytokines (IL-4 and IL10) compared with obese animals (OZR-C).
Hypothesis 2. Eight weeks of treadmill running in combination with eight weeks of UCMS
(LZR-EXS) will attenuate the stress-related increase in pancreatic TXNIP, pro-inflammatory
cytokines (e.g., IL-1β, IL-6, and TNFα) and apoptosis and a decrease in anti-inflammatory
cytokines (IL-4 and IL-10) compared with lean stressed animals (LZR-S).
Hypothesis 3. Eight weeks of treadmill running will attenuate the combined effects of obesity
and UCMS (OZR-EXS) on pancreatic increases in TXNIP, pro-inflammatory cytokines (e.g., IL-
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1β, IL-6, and TNFα) and apoptosis and a decreases in anti-inflammatory cytokines (IL-4 and IL10) compared with obese stressed animals (OZR-S).
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CHAPTER 2: LITERATURE REVIEW
Pancreas
The pancreas is an organ in the body responsible for maintaining glucose homeostasis
through the counter-regulatory actions of insulin and glucagon.29,30 There are many types of cells
in the pancreas that make up the islet of Langerhans, including b-cells that produce insulin, acells that produce glucagon, somatostatin, ghrelin, and polypeptide-secreting endocrine cell types
that each produce a unique hormone. Eight-five percent of the pancreatic tissue is made up of
exocrine cell types, such as acinar cells that produce digestive enzymes and duct cells that
produce a conduit to the gut for digestive enzymes.31,32 The remaining fifteen percent is made up
of the pancreatic islets, which consist of approximately seventy-five percent b-cells and twenty
percent a cells.33
Blood glucose is important for the stimulation of b-cell growth in fetal and adult life.34
Blood glucose levels modulate the release of insulin from the pancreatic b-cells when blood
glucose is high, a process known as glucose-stimulated insulin secretion. 29,35 When glucose
levels are low, glucagon is released from the pancreatic a-cells, and this triggers glycogenolysis
and gluconeogenesis by the liver to increase glucose levels.30 A rise in blood glucose level
triggers glucose oxidation via glycolysis and the Krebs cycle within the pancreas and an increase
in cytosolic ATP/ADP ratio that leads to an influx of free Ca2+, triggering a signal for insulin
secretion from pancreatic b-cells (Figure 1).29,35,36
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Figure 1 shows the process of glucose entering the human b-cell through the GLUT 1 (GLUT 2
in rodent) receptor and proceeding through the Krebs cycle to produce ATP. Potassium channels
then close off, depolarizing the membrane to allow calcium channels to open, triggering the
release of insulin from the b-cells.36
The development of pancreas tissue involves apoptosis, replication, and neogenesis.
During the neonatal period, the pancreas undergoes substantial remodeling, and apoptosis is a
major process determining the final b-cell mass.37 There are two process by which pancreatic bcells develop: differentiation and proliferation.34,38,37 Neoformation of pancreatic b-cells occurs
from the differentiation of precursor cells.34 Proliferation of pre-existing pancreatic b-cells is a
key component in regeneration.38 It has been suggested that pancreatic b-cells derive from acells, in that a-cells develop first in the embryo. Figure 2 shows the process of development of
the cells in the pancreatic islets.39 When insulin resistance leads to T2D, it is suggested to be a
9

bi-hormonal disease with hypoinsulinemia (b-cells) and hyperglucagonaemia (a-cells). Though
this could suggest changes to a-cell mass in the pancreas with the progression to T2D, the a-cell
to b-cell ratio increases with T2D when compared to non-diabetic pancreas islets due to
decreases in b-cell numbers, with no significant changes occurring to the a-cell number.40

Figure 2 shows the development of pancreatic b-cells and a-cells.39
Insulin resistance is a process that develops gradually as pancreatic b-cells overproduce
insulin to compensate for the onslaught of blood glucose until these cells begin to experience cell
death. The periphery becomes resistant to the effects of insulin after circulating insulin remains
consistently elevated.41 This is characterized by diabetes, which is subdivided into two pathways
of dysfunction: type 1 diabetes (T1D) and type 2 diabetes (T2D). T1D is an autoimmune disease
that results in complete exogenous insulin dependence due to pancreatic b-cells being destroyed
and unable to sufficiently produce insulin. T2D is a progressive disease that is also known as
insulin-independent diabetes. Under extreme conditions, like morbid obesity, T2D can progress
into total insulin-dependence, though this is rare.42,43,44
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There are five stages to the development of insulin resistance: compensation, stable
adaptation, unstable early decompensation, stable decompensation, and severe decompensation.42
The compensation stage is found to be highly associated with obesity and involves upregulated
insulin secretion and increased GSIS following a glucose challenge.42,43 This increase in insulin
is suggested to be brought about by increased b-cell mass as has been observed postmortem in
obese patients.42,45 The stable adaptation stage involves pancreatic b-cells unable to compensate
for the high glucose levels. This stage is considered stable because those individuals who adhere
to a healthy diet and regular exercise regimen progress at a much slower rate to T2D.42,46 Stage 2
is characterized by fasting glucose levels between 5.0 and 7.3 mmol/l, the loss of GSIS, and
changes in b-cell differentation.42,47 Patients can remain in stage two for years, but once b-cells
can no longer compensate and b-cell mass declines, glucose levels rise substantially over a short
period of time. This has been characterized as the unstable early decompensation stage (stage
three). Stage four will most likely be maintained throughout the lifetime of a patient of T2D.
Those individuals with T1D have a rapid autoimmune destruction of b-cells that lead to stage
five, which is severe decompensation. Stage five is rarely reached with T2D.42
Two contributors to the development of T2D include chronic stress and obesity.48,49,50
Both of these processes promote inflammation, increased oxidative stress, and apoptosis,
including but not limited to pancreatic b-cell death. Chronic stress has been associated with an
increase in obesity, and obesity can promote chronic stress.51 Both of these comorbidities are
associated with increased GCs, hyperglycemia, hyperinsulinemia, and increased FFA, along with
others, all of which can be associated with insulin resistance.4,7, 8,9,11,12,13,15
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Metabolic Syndrome
The Metabolic Syndrome is a noninfectious pandemic that involves organs such as the
heart, liver, adipose tissue, pancreas, etc.52 Of the estimated 200 million overweight Americans,
over 50 million are estimated to be affected by the Metabolic Syndrome.52 This disease is a
cluster of factors that are linked to increased risk for diseases such as diabetes, cardiovascular
disease, cancer, etc. These factors include abdominal obesity, high blood glucose levels (insulin
resistance), dyslipidemia, high cholesterol or low HDL-C levels, and hypertension.3 It is
suggested to be due mostly to the environment, with little influence from genetics.53,54,55 From
1970 to 2003, the caloric intake in the United States increased by 523 calories, while advances in
technology have led to a more sedentary lifestyle.54,55 Proinflammatory markers have been
shown to positively correlate with features of the Metabolic Syndrome, like insulin resistance
with no correlation to the degree of obesity. These proinflammatory markers include TNF-a, IL6, IL-1b, and other chemokines.56 Vozarova and colleagues57 showed a correlation with high
white blood cell (WBC) count, an indicator that the immune system is activated, and the
development of diabetes. Phillips and Perry58 showed a positive correlation with metabolically
healthy individuals and lower levels of IL-6 and WBCs and higher levels of adiponectin.

Obesity
Obesity is the accumulation of adipocytes in the form of adipose tissue. Adipocytes are
cells that store fat in the form of triglycerides (TGs) as energy for times of starvation.53 In order
to avoid lipids from accumulating in non-adipose tissue, adipocytes not only serve as the storage
for TGs, but these cells also secrete leptin to signal the brain that satiety is reached and stimulate
fatty-acid oxidation in those non-adipose tissues.53
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As energy intake increases and energy expenditure decreases, adipose tissue accumulates
via hypertrophy, or in serve conditions, hyperplasia.59 Organs involved in the Metabolic
Syndrome, like the pancreatic islets, accumulate ectopic fat in both humans and rodents.60 It was
shown in overweight humans using magnetic resonance spectroscopy (MRS) that the pancreas
accumulates TG deposits.61 When glucose tolerance is impaired, or in the presence of diabetes,
fat accumulation in the pancreas is significantly even greater.61 This is suggested to be
glucolipotoxicity, where increased glucose further promotes lipogenesis and lipotoxicity.62
Adipose tissue is an active endocrine organ known to secrete free-fatty acids (FFA) and
adipokines, such as cytokines and chemokines.59 This action may contribute to the development
of metabolic diseases through hyperglycemia, dyslipidemia, and inflammation.59 It has also been
shown that obesity stimulates the production of reactive oxygen species (ROS) via increased
FFA being released by adipose tissue into circulation.63 All of these actions can lead to the
development of insulin resistance.

Inflammation and Obesity
Macrophage content of adipose tissue is positively correlated with body mass and
adipocyte size, and these macrophages secrete cytokines like TNF- a, IL-6, and IL-8, which are
associated with insulin resistance.7 Macrophages are the key immune cells involved in adipose
tissue inflammation in obese individuals, and during chronic exposure to inflammation,
macrophages within the adipose tissue impair adipocyte function.64,65,66 Macrophages are cells of
the innate immune system and serve as a link between the innate immune system and the
adaptive immune system.13,64 Obesity has been shown to induce a phenotypic change in
macrophage polarization, from M2 to M1 (Manti to Mpro). 13,65 M1 are macrophages that are crucial
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for fighting bacterial infections and tumors, but excess activation leads to a proinflammatory
environment that can cause tissue damage. In order to fight off infections, M1 secrete ROS, nitric
oxide (NO), and proinflammatory cytokines, such as TNF-a, IL-1b, and IL-6.13 TNF-a is one of
the first cytokines produced in this process, and along with the proinflammatory cytokine IL-1b,
it can induce the production of IL-6, which can be both a proinflammatory cytokine and an antiinflammatory cytokine, depending on its origin (i.e. skeletal muscle produces IL-6 in an antiinflammatory fashion, while adipose tissue produces a proinflammatory IL-6).13,67,68,69 The M2
pathway is an anti-inflammatory pathway that produces anti-inflammatory cytokines such as IL10 to suppress inflammation.13,70
Macrophages have been suggested to be linked to insulin resistance, more specifically
through the release of proinflammatory cytokines such as TNFa.64,66 TNF-a is thought to be a
major cause of the development of insulin resistance, and it has been shown that obese mice that
lack either TNF-a or TNF-a receptors are protected from developing insulin resistance.71,69 In
rodent models, mice deficient in TNF-a show decreased levels of FFA and TGs when compared
to control mice, and rodents subjected to TNF-a showed impaired action of glucose uptake by
the skeletal muscle.72 Advances in insulin sensitivity were not mimicked in humans with antiTNF-a treatments.73 TNF-a increases lipolysis in adipose tissue to release FFA into systemic
circulation. FFA are then able to deposit in non-adipose tissues, like skeletal muscle. 71,74,75
In humans, 10-35% of circulating IL-6 is housed in adipose tissue, and so hypertrophy of
adipocytes is accompanied by an increased production of adipose tissue IL-6.76,77 It has been
shown that expression of IL-6 from adipose tissue positively correlates with insulin resistance,
and so when neutralization of TNF-a in humans brings about no improvement in insulin
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sensitivity, it can be suggested that IL-6 makes up for the absence of the effects of TNF-a.78,79
Hyperglycemia has also been associated with increases in IL-6 levels from adipose tissue.80

Oxidative Stress and Obesity
Obesity has been observed to increase oxidative stress, which is known to cause direct
and indirect damage to organs that can result in many pathological processes, including the
Metabolic Syndrome.63,81 Biomarkers for oxidative stress have been shown to be correlated
directly with many factors involved with obesity, including BMI, percent body fat, LDL
oxidation, and TG levels, and it has been shown that these biomarkers are increased in diets high
in fat and carbohydrates.82,83 As stated above, obesity is associated with a proinflammatory
environment through the overproduction of cytokines, which are known to increase ROS and
NO. TNF-a causes damage to the mitochondria in the mitochondrial chain complex III and
activates the production of ROS at the ubiquinone site.84,85 This was further investigated by
inhibiting mitochondrial oxidative metabolism, which not only lead to the inhibition of TNF-a
cytotoxicity, but also reduced TNF-a activation of nuclear-factor kappa-b (NF-kb) and IL-6.85,86
With obesity there is a higher demand on the heart, and therefore an increase in mitochondrial
respiration; this leads to the consumption of more oxygen, and the production of more ROS in
the form of superoxide and hydrogen peroxide.63 It has been shown that hydrogen peroxide is
increased in obese mouse adipose tissue, and along with the fact that adipose tissue was the only
observed organ that had increased hydrogen peroxide levels, can suggest that adipose tissue is
the major producer of this oxidative stress biomarker.63
The adipokine, adiponectin, has insulin-sensitizing effects that increase insulin
sensitivity.59 Adiponectin is shown to be reduced in obese individuals, and it has been shown that
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plasma adiponectin levels are inversely related to oxidative stress biomarkers in nondiabetic
human subjects.63,87 In rodent models, the absence of adiponectin is shown to induce insulin
resistance, whereas overexpression of this adipokine leads to increased insulin sensitivity.

Obesity’s Effects on the Pancreas
Excess circulating lipids are taken up by the pancreas and other organs, leading to lipid
accumulation in those organs.88 It was shown in obese homozygous (fa/fa) male ZDF rats that
apoptosis in the pancreatic islets was increased as prediabetic and diabetic stages progressed. It is
suggested that elevated levels of circulating FFA and lipoproteins transport more FFA than the
pancreas can oxidize, leading to a lipotoxic effect on islets.89 Excess circulating lipids were
associated with diminished pancreatic b-cell function and even apoptosis in in vivo rat models
and in vitro human islet cells.90 It is suggested that ceramides are a mediator of the FFAinduction of pancreatic b-cell apoptosis.89
Lipotoxicity and glucotoxicity in the pancreas have been shown to increase ER stress
through JNK activation, leading to decreases in b-cell mass in animal studies.91,92 On the other
hand, Saisho and colleagues93 found that in human pancreas autopsies that b-cell mass was
increased with obesity. Oxidative stress is known to cause damages to many organs, including
impairment of insulin secretion in pancreatic b-cells and impairment of glucose transport into
muscle and adipose tissue.94,95,96 The adverse effects of ROS on insulin production not only leads
to insulin resistance, but also may lead to b-cell apoptosis.88 ER stress in the mitochondria of the
pancreatic b-cell can lead to the overproduction of ROS, and obesity has been associated with
this increase in ER stress-induced oxidative stress in the mitochondria.88
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General Stress Response
Chronic stress is a modifiable risk factor for T2D and insulin resistance.14 Organisms
have a primal instinct to survive, and this requires physiological adaptations that must occur
when homeostasis is threatened.97 When a stressor is perceived by the brain, a cascade of signals
activates the HPA axis, and GCs are released.97,98,99,100,17 The stressor promotes corticotropinreleasing hormone (CRH) to initiate the stress response in the hypothalamus and flow through
circulation to the anterior pituitary gland to stimulate the release of adrenocorticotrophic
hormone (ACTH).97,99,100,16 When ACTH reaches the systemic circulation the adrenal glands are
stimulated to release GCs (cortisol in humans and corticosterone in rodents) that are then
pumped into the systemic circulation.97,99,100,16 In an acute stress response, GCs act as a negative
feedback mechanism to the hypothalamus to stop the release of CRH to turn off the stress
response cascade.97 When in circulation, GCs bind to their receptors, GRs to help modulate a
number of biological functions due to GRs being expressed in almost all cell types. In immune
cells and other organs and tissues, including adipose tissue, GCs are one of the key regulators of
energy influx in adipocytes. 98,100
This release of GCs allows for energy to be mobilized for one of two reasons: 1) a
reactive response, in which energy is needed to meet a physical insult, or 2) an anticipatory
response, in which energy is assembled to prepare for a predicted need.97 Energy is mobilized
through the binding of GCs to glucocorticoid receptors (GR) in the hypothalamus and pituitary
glands of the brain that promote mobilization of energy stores for the liver, fat, and muscle and
increase inflammation and neural function.101 GR receptors are considered to lead the bulk of
feedback regulation.97 GCs work to increase the liver glucose output and the release of FFA from
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white adipose tissue along with the reduction of insulin secretion so that energy can be available
for behavioral reactions to stressors.102

Glucocorticoids and Obesity
When under chronic psychological stress, it has been shown that there is a tendency for
overconsumption of energy dense foods. 98,103 Chronic stress has been shown in both humans
and rodents to trigger the desire for high fat, energy dense foods.104 Even in instances in which
stressed subjects do not gain weight, it is still shown that high fat and/or sweet foods are
favored.104 It has been shown in animal studies that under chronic mild stress, rodents saw
weight gain and increased food consumption when sweet condensed milk was offered in
comparison to regular chow.105,106 In humans, chronic stress induces an increase in cortisol that
may lead to an increased consumption in energy-dense food, which could lead to weight gain.107
Some key components of obesity are hyperglycemia, or high blood sugar.,
hyperinsulinemia, and insulin resistance. In acute stress conditions, GCs exposure can lead to
decreased skeletal muscle glucose transport and increase hepatic glucose production.5,108 Acute
exposure to GCs can improve pancreatic b-cell function to glucose sensitivity and insulin
secretory capacity, but chronic exposure to the stress hormone can lead to dysfunctions including
impaired peripheral insulin sensitivity and decreased GSIS.20 Chronic exposure of GCs can
result in damage to the pancreas that can lead to insulin resistance, hyperinsulinemia, and
hyperglycemia when chronically stimulated, which can lead to deteriorated glucose homeostasis.
98,109,5,9

Chronic stress can promote increased abdominal obesity and excess ectopic fat

deposition.98,5,108 Humans subjected to chronic GC treatment (>14 days) showed decreases in
insulin secretion when subjected to a glucose challenge. This impairment in insulin action could

18

suggest an indirect loss in pancreatic b-cell function or suppression of the release of insulin by
pancreatic b-cells.110,111 This could suggest that over time, chronic exposure to stress and GCs
can lead to insulin-dependent diabetes through the elimination of pancreatic b-cells. It was also
shown that increased endogenous glucose production, as well as lipolysis, increased plasma freefatty levels.110,111 This goes along with the belief that GCs cause metabolic and morphological
attenuations to the pancreatic b-cells.20,112 Chronic GC exposure has been shown to increase bcell mass due to hypertrophy and hyperplasia, which can lead to hyperinsulinemia.20 GCs have
been observed to favor glycogenolysis activation, gluconeogenesis, lipid mobilization, and
protein synthesis inhibition, which can lead to increased blood glucose and in turn
hyperinsulinemia.112 These different responses in the pancreatic b-cells to chronic exposure to
GCs could be due to differences in the progression of pancreatic damage brought about by the
chronic exposure to stress.

Inflammation and Chronic Stress
The HPA axis is one of the main mechanisms the brain utilizes to control the immune
system, and stress has been shown to have deleterious effects on the immune system.99 GCs are
known to be primarily an anti-inflammatory defense. 17,109 In acute situations, GCs combat the
immune cells; at a cellular level, GCs induce apoptosis in T lymphocytes, neutrophils, basophils,
and eosinophils and modulate macrophage cytokine production by inhibiting p38 MARK at the
transcriptional level.100,113,114 GCs are known to suppress proinflammatory cytokines such as IL6 and TNF-a and upregulate the secretion of anti-inflammatory cytokines like IL-4, IL-10, and
IL-13.16,115 GCs have also been shown to downregulate IL-1b transcription.116 Corticosterone
enters the nucleus to inhibit the transcription control pathways, including NF-kb, mitogen-
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activated protein kinases (MAPKs), and others.16,117 GCs have also been studied to promote the
Th1 to Th2 shift, meaning they suppress proinflammatory (Th1) processes and upregulate antiinflammatory (Th2) cytokines.16,118 GCs act to suppress the production of IL-12, the main
inducer of the Th1, or proinflammatory, response.16,118
Although GCs can be used for therapeutic benefits in conditions like rheumatoid arthritis
or Addison’s Disease where the adrenal glands are not producing GCs, high doses of GCs are
associated with diabetes, hypertension, and other diseases risks.100,119,120 Cushing’s Syndrome is
the excess production of GCs, and like chronic stress can overstimulate the HPA axis causing
immune cells to become less sensitive to GCs.100,17,121 Chronic stress can lead to changes in
lymphocyte populations, changes in NK cell number and activity, changes in ratio of helper:
suppressor T cells, impaired antibody responses, etc.99
Lymphocytes are mediators in cell immunity, and T lymphocytes are divided into four
subgroups: cytotoxic T cells (CD8+ T cells that destroy non-self-cells), helper T cells (CD4+ T
cells that secrete cytokines), memory T cells (either CD4+ or CD8+ T cells that are antigenspecific), and regulatory T cells (suppressor T cells that suppress antibody production).99
Stressors have been shown to have varying effects on the T lymphocytes, including: decreases in
total T lymphocytes, helper T lymphocytes, and suppressor T lymphocytes122,123; decreased
helper-to-suppressor T lymphocyte ratio122,124; increased levels of CD8+ cytotoxic T cells125; and
poor memory T cell proliferation.126,127 Natural killer cells, cytotoxic T lymphocytes that
primarily kill viral infections and cancer, experience a decrease in number and activity in
response to stressors; this leads to a decrease in the ability to fight infection.99 Stress has been
shown to have differing effects on immunoglobins in the absence of infection, including
increasing plasma IgA without changes in IgG, IgM, and salivary IgA during examination
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stress,128 increases in IgG, IgM, and IgA during examination stress,99 and in mice, decreased
serum IgM with footshock.129 Also, white blood cells develop a counterregulatory response to
downregulate the function of receptors responsible for binding and reacting with GCs.121 This
allows for a proinflammatory environment to collect with chronic stress.17,121
Cytokines are divided into two subsets: Th1 cytokines, or proinflammatory cytokines,
which include IL-1, IL-2, IL-6, INFg, and TNF-a; and Th2 cytokines, or anti-inflammatory
cytokines, which include IL-4, IL-5, IL-10, and IL-13.99 With chronic stress, studies have shown
the development of glucocorticoid-resistance syndrome, where GCs can no longer suppress
cytokine production,16 or glucocorticoid-receptor resistance, where a decrease in the immune
cells sensitivity to GCs allows for increased for chronic inflammation.17 Studies have shown that
with prolonged stress, the ability to suppress the secretion of IL-6, IL-1b, and TNF-a is
diminished, allowing for the upregulation of proinflammation.99,17,117,130,131 GCs have also been
shown to induce the activation of the NLRP3 inflammasome, a NOD-like receptor that is a major
producer of IL-1b, a proinflammatory cytokine.132

Oxidative Stress and Chronic Stress
Apoptosis is programmed cell death that, under normal conditions, helps remove
damaged or aged cells and maintain homeostasis.133,134 Excess oxidative stress causes cell death
through apoptosis. 135,136 Too much apoptosis can lead to adverse consequences, and
hyperglycemia is a pathophysiological component that induces both oxidative stress and
apoptosis.29 Glucocorticosteroids and TNF-a can both stimulate apoptosis through severe
oxidative stress.29
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Oxidative stress is also thought to contribute to glucotoxicity, an effect that can be
brought about by over nutrition and the steady increase in high blood glucose levels that can lead
to the development of conditions such as type 2 diabetes.29 In hyperglycemic conditions, more
glucose is circulating through the glycolytic pathways and therefore increasing the amount of
pyruvate and acetyl-CoA being produced. This process produces NADH, an electron carrier, and
in hyperglycemic conditions, there is a surplus of NADH produced, creating electron pressure on
the mitochondria electron transport chain, especially in the pancreatic b-cells.137,138,139,140 The
mitochondrial complex I (MC-I) functions to recycle NADH, and when hyperglycemia
overproduces NADH, a heavy burden is placed on MC-I.141,142 This increased cycling of NADH
through the MC-I produces more superoxide, the precursor for all ROS, through the leakage of
electrons that can reduce oxygen to superoxide.141,143,144,145 The four major sources of ROS are
oxidative burst, oxidative processes, lipid peroxidation, and oxidative stress.146
In depression, oxidative stress is increased and antioxidant defenses are decreased.147 In
patients with depressive disorders, plasma, serum, and urine samples have shown increases in
total oxidative status, oxidative stress index, and markers of lipid peroxidation.148 It was also
shown in peripheral blood samples of depression patients that mitochondrial ROS production,
nitric oxide levels, and lipid peroxidation were all increased while the antioxidant markers
superoxide dismutase (SOD) and GPx were decreased.149,150,151,152 In the postmortem
hippocampus of patients that suffered depression or bipolar disorder, there was an increased
RNA oxidation observed, as well as decreases in antioxidant marker GPx in the frontal
cortex.153,154 These results suggest that, while oxidative stress can be a consequence of
depression, it also contributes to and increases the progression of depression.155
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UCMS Protocol
The unpredictable chronic mild stress (UCMS) protocol, also known as CUMS, CMS,
etc., can be used to induce stress in the rodents to mimic stress in humans. These protocols
induce stress presents similar behaviors to that of depression in rodents, presenting itself such
that rodents show anhedonia-like behavior and other behaviors that suggest depression is
present.112,146,148 The protocols success can be measured in different ways, including coat score
assessment, behavior testing, and corticosterone measurements. Rodents undergo a randomized
schedule of stressors, including bath, cage tilt, damp bedding, wet bedding, and social stress.
These are outlined in detail in the methods section. The schedule is randomized for each day,
with different stressors and different durations to make sure that the animals do not grow
accustomed to the stressors. Coat scores are assessed at the end of each week by the same
individual, and the blood samples taken the day of surgery are used to measure corticosterone
levels.
In a study done by López-López and colleges,112 the pancreas was examined in relation to
oxidative stress caused by chronic, unpredictable, mild stress (CUMS). Corticosterone was
increased with the stress protocol, as well as lipoperoxide concentration in the pancreas gradually
from day 20 to day 60. This was shown by the increased levels of lipid peroxidation and
oxidative proteins in the pancreas, along with decreases in total antioxidant capacity with the
stress protocol. The pancreas is a regulator of the metabolism of carbohydrates, lipids, and
proteins, and is not equipped as a major regulator of the redox state of an organism.112
The liver is the major site for antioxidant enzyme capacities in the body and is considered
the regulatory organ for the redox state.112,148 The CUMS protocol resulted in an increase in
oxidative stress markers and lipid peroxidation in the liver, though total antioxidant capacity did
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not significantly decrease over the 60-day duration.112 Duda and colleagues148 used chronic mild
stress (CMS) to show the increase markers of oxidative stress, including ROS, malondialdehyde
(MDA), and non-protein sulfhydryl (NPSH), while the antioxidant markers catalase (CAT) and
glutathione peroxidase (GPx) increased as well within the liver.

Exercise and Obesity
Regular exercise is associated with better quality of life and health outcomes.156 Exercise
has been shown to improve physical attributes of health, including reduced blood pressure,
enhanced cardiovascular fitness, increased insulin sensitivity, reduced abdominal adiposity, and
prevention of chronic diseases, such as diabetes and obesity.157,158 Even short-term exercise has
been shown to improve many aspects of the Metabolic Syndrome.156 A 12-week exercise
program in middle-aged women resulted in decreases in blood pressure, body fat percentage,
fast glucose levels, triglycerides, and cholesterol.159
Exercise has been shown to enhance the loss of adipose tissue, which can in turn reduce
the proinflammatory environment brought about by adipocyte hypertrophy.158 In a study with
severely obese human subjects, 15-weeks of hypocaloric diet and daily exercise resulted in
decreased circulating inflammatory markers and decreases in adipose tissue expression of
inflammatory markers, such as IL-6 and TNF-a. The lifestyle intervention also produced
increases in adiponectin and improvement in metabolic status.160 Though a high-fat diet was
shown to increase obesity, inflammation, and insulin-resistance, voluntary exercise reduced these
parameters. Voluntary exercise not only reduced the inflammation brought about by the HFD,
but this intervention also reduced inflammation in the exercise-regular chow diet.161
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Exercise and Stress
Depression has been associated with low levels of physical activity, and regular exercise
has been shown to improve mental health.162,157 Individuals with depression spent significantly
less time in light and /or moderate physical activity than did non-depressed adults, while adults
that lived a physically active lifestyle showed reduced depression symptoms.163,164 Sedentary
lifestyle has been demonstrated to have a direct relationship with depression.162 Exercise has
been advocated as a means to improve mood and depressive-type mental disorders through
physiological and psychological processes, including improved mood state, enhanced selfesteem, and lower stress and anxiety.157 In a study done by DiLorenzo and colleagues,165 aerobic
exercise showed not only improvements in health parameters, but also in many aspects of
psychological well-being, including depression, anxiety, self-concept, and vigor. In obese and
overweight individuals, increasing moderate-to-vigorous physical activity and decreasing
sedentary time resulted in lower risk for the development of depression.166
In animal studies, regular exercise caused alterations in serotonergic and noradrenergic
systems, which are targeted by pharmacological treatments for depression.167 Treadmill running
with rats was shown to increase levels of blood tryptophan, allowing the brain to produce an
increased rate of synthesis of serotonin, 5-hydroxyindoleacetic acid (5-HT).168 Exercise
promoted increases in 5-HT turnover in the hypothalamus in rats. In rats exposed prenatally to
high level of GCs, four weeks of swimming exercise resulted in decreased levels of serum
corticosterone and depressive behavior.169 HPA-axis activity decreased in rats exposed to lowintensity stressors with six-weeks of intermittent, voluntary wheel running.170 171
In humans, ten weeks of moderate-intensity exercise produced anxiolytic effects
correlated with a downregulation of postsynaptic serotonin receptors and with a blunted cortisol
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response to the 5-HT2C agonist, meta-chlorophenylpiperazine (m-CCP).172,173 In a human crosssectional study of 269 adult subjects, regular exercise was shown to reduce anxiety and lower
depression, and in 7 randomized controlled studies, regular exercise was associated with reduced
stress and decreased anxiety.174,175 In a study done with patients with major depressive disorder
(MDD), a single bout of treadmill running resulted in improved mood.176

Thioredoxin System
There are two main antioxidant systems in mammalian cells, the thioredoxin (Trx)
system and the GPx system.177 The thioredoxin system is a pivotal component in the antioxidant
defense system and is comprised of three components: NADPH, thioredoxin reductase (TrxR),
and Trx.22,177,178,179 The Trx system defends against oxidative stress by the reduction of disulfide
activity and regulating the dithiol/disulfide balance in cells.177,178,179 Trx1 is found in the cytosol
and nucleus, while Trx2 is located in the mitochondria.22,178,179 The Trx system plays a role in
reversing oxidative modifications, like sulfenylation and nitrosylation.155 Trx1 becomes oxidized
and inactivated after it reduces oxidized cysteine groups on intracellular proteins, and TrxR then
can re-activate this oxidized Trx by reducing it through the use of NADPH.177,22,179 Trx2 binds
apoptosis-signaling kinase-1 (ASK-1) in the mitochondria and renders it dormant, allowing for
the inhibition of ROS, inflammation, and apoptosis. 155,180,181,182 Trx plays a crucial role in many
protective mechanisms, including limiting apoptosis, protective anti-oxidant mechanisms, like
breaking down hydrogen peroxide into water, and DNA synthesis and repair.177,178,179
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Thioredoxin Interacting Protein
Thioredoxin-interacting protein (TXNIP) has also been referred to as vitamin Dupregulated protein and thioredoxin-binding-protein-2.22 This protein has structural
characteristics that fit the a-arrestin family, and has distinct binding sites for proteins like ASK-1
ubiquitin ligase, and others.183 TXNIP acts to inhibit the antioxidant capabilities of the Trx
system.22,24,184,185,23 TXNIP is a proapoptotic factor that has been thought to be a key player in
the glucotoxic b-cell death that is associated with insulin resistance and diabetes.24,185 TXNIP is
localized to the nucleus in pancreatic b-cells, but “shuttles” to the cytoplasm and/or mitochondria
of the pancreatic b-cells (Figure 3).22,23,25 Oxidative stress induced by hydrogen peroxide (H2O2)
has been shown to lead to shuttling of TXNIP into the mitochondria by TXNIP binding to
importin-a.23 Within the mitochondria, TXNIP competes with ASK-1 for the binding site on
Trx2, causing ASK-1 to be released and phosphorylated; this can further lead to mitochondrial
dysfunction and apoptosis (Figure 3).22,23,25,186 It was shown with Trx2 knockdown in INS-1 bcells that phosphorylation and activation of ASK-1 and activation of mitochondrial death
pathways were increased. This mitochondrial death pathway was assessed via increases in
activated caspase-3. It was also shown that increasing mitochondrial TXNIP resulted in
increased Trz2 oxidation, decreased Trx2-ASK-1 binding, and increased phosphorylation and
activation of ASK-1.23 Within the cytosol, TXNIP binds to reduced Trx1, inhibiting the ability of
the antioxidant system to reverse protein cysteine oxidative modifications.22,27,155,178
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Figure 3 depicts the processes by which TXNIP interferes with the thioredoxin system in the
pancreatic b-cell cytoplasm, mitochondria, and nucleus.25
TXNIP has been suggested to be the link between glucose toxicity and pancreatic b-cell
apoptosis, such as that seen in diabetes. 24,184,185 In both obese and non-obese diabetic mice,
TXNIP expression is shown to be elevated in pancreatic b-cells.184,185 Incubation of human
pancreatic islets in high glucose concentrations for 24 hours resulted in a five-fold increase in
TXNIP expression when compared to islets incubated in low glucose concentrations. 24,184 INS-1
b-cells incubated in high glucose concentrations resulted in increased TXNIP levels 18-fold
along with a 12-fold increase in cleaved caspase-3.184,185 Overexpression of TXNIP resulted in
increases in cellular levels of ROS and free radical-mediated stress to b-cells by H2O2, while
overexpression of Trx inhibited the ROS increase.24,185 TXNIP knockout gene shows reduced
hyperglycemic-induced increase in oxidative stress.24 Glucose-induced TXNIP increases also
showed apoptosis in pancreatic islets of INS-1 cells, including increases in the Bax
(proapoptotic) to Bcl-1 (antiapoptotic) ratio, increases in cleaved caspase-3, and TUNEL positive
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b-cells.184,185 Glucose is shown to induce TXNIP transcription via a carbohydrate response
element (ChoRE).184

TXNIP and Chronic Stress
A study with INS1 b-cells and human and mouse pancreatic islets demonstrated that
treatment with glucocorticosteroids led to increases in TXNIP expression, and that expression
was even more pronounced than in hyperglycemic conditions. Over time, these increases in
TXNIP were accompanied by the induction of pancreatic b-cell death.187 Chronic stress
associations with increased TXNIP expression have been reported in other organs as well. In a
study by Zhou and colleagues, rodents that experienced chronic stress had significantly elevated
TXNIP expression in the hypothalamus and frontal cortex when compared to control mice. In
addition to increases in TXNIP, increases in protein sulfenylation and nitrosylation and increases
in phosphorylated ASK-1 in the hypothalamus and frontal cortex were also observed. It is
proposed that increases in corticosterone due to stress lead to these increases in TXNIP and its
downstream regulators.155 Bharti and colleagues188 showed that treatment of neuronal cells with
human cortisol resulted in increased expression of TXNIP in the nucleus and cytoplasm, and that
GR inhibition lead to blockage of the cortisol-induced TXNIP expression. Whether chronic
stress also causes an increase in TXNIP within the pancreas remains to be determined.

NLRP3 Inflammasome
The nod-like receptor protein 3 (NLRP3) inflammasome is a major producer of IL-1b, a
proinflammatory cytokine associated with insulin resistance (Figure 4).22,27,189,190 This
contribution to the proinflammatory environment can also promote increases in proapoptotic
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proteins, cleaved caspase-3 and cleaved PARP-1, which activate the apoptotic pathway P38
MAPK-JNK.22 TXNIP has been suggested to activate the NLPR3 inflammasome, triggering the
production of IL-1b.22,27,189 TXNIP binds to the leucine rich repeat (LRR) region of the
inflammasome, and the activation is dependent on the generation of ROS, as all NLRP3
activators are known to generate ROS.27,191 This is furthered supported by the induction of
NLRP3 inflammasome activity and IL-1b secretion by addition of H2O2 in THP-1 human
macrophages.27,191 When TXNIP expression was suppressed, H2O2-driven inflammasome
activation was blunted, as shown by suppression of IL-1b and caspase-1.27

Figure 4 explains the role of adipose tissue NLPR3 inflammasome activity and its effects on
other organs. The secretion of mature IL-1b by the adipose tissue is associated with insulin
resistance.190
A HFD is accompanied by significant increases in the interaction of TXNIP with the
NLRP3 inflammasome, along with significant increases in cleaved IL-1b and cleaved caspase-1
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and expression of TXNIP and mature IL-1b. Mohamed et al incubated human retinal endothelial
cells in palmitate-BSA to mimic HFD and found that the interaction of TXNIP and the
inflammasome was increased, resulting in the activation of caspase-1 and IL-1b. To further
confirm these results, TXNIP was silenced and resulted in the abolishment of the palmitate-BSA
increase of cleaved IL-1b and decreases in cell death, as shown by decreases in proapoptotic
cleaved caspase-3 and larger proportion of live cells to dead cells.189
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CHAPTER 3: METHODS AND MATERIALS
Animals
32 male OZRs and 32 male LZRs, ages 7-8 weeks, were obtained from Harlan. All rats
were acclimatize to their environment for one week in the West Virginia University Health
Sciences Animal Facility then placed on a reverse 12 hour light-dark cycle. LZRs and OZRs
were then randomly assigned to four groups: 1) sedentary controls (C: n=8); 2) unpredictable
chronic mild stress (S: n=8); 3) exercise (EX: n=8); and 4) a combination of UCMS and Ex (EXS:
n=8). All rats received standard chow and tap water ad libitum, and protocols received approval
from the WVUHSC Animal Care and Use Committee prior to the start.

UCMS Protocol
The UCMS protocol was developed to produce depression-like behaviors in
rodents.112,146,148 This approach is the most appropriate model for clinical depression in rodents
and mimics human-like depression behaviors, including anhedonia and learned helplessness.192
During the UCMS protocol, rats were singly housed, and randomly exposed to the following
mild environmental stressors for 8 hours each day, 5 days per week, over the 8 week course:
1. Damp bedding – 10 oz. of water was added to each standard cage
2. Bath – all bedding was removed and ~0.5 inches of water was added to the empty
cage. Water temperature was at room temperature, ~24°C
3. Cage tilt – cage was tilted to 45 degrees without bedding
4. Social stress – each rat was switched into a cage of a neighboring rat
5. No bedding – all bedding was removed from the cage
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6. Alignment of light/dark cycles – turning the lights off/on in random increments for a
scheduled period
The protocol was altered each day to prevent rats from habituating to the stress.192

Exercise Training Protocol
EX and EXS groups underwent 8 weeks of treadmill running, 5 days per week on multilane motor driven treadmills set at a 5% grade. The animals were acclimatized during the first
week by running for 20 minutes then increasing by 10 minutes per day until a sustainable
duration of 60 minutes daily was achieved. A maximum speed test was conducted on each rat to
determine a target-running speed of 60-70% of the determined maximum. Once acclimatized,
rats exercise for 60 minute per day. During the first 15 minute, the treadmill speed was gradually
increased until the targeted-running speed was reached. At that point, the rats continued running
at the targeted-running speed for the remaining 45 minutes. To discourage rats from stopping, a
mild electrical stimulus (£ 0.3mA) was used at the rear of the treadmill. At the end of the 8-week
exercise protocol, there was a 48-hour wash out period between the last bout of Ex and the
terminal surgery.

UCMS and Exercise Combination Protocol
LZRs and OZRs assigned to the EXS group preformed the treadmill running first thing in
the morning (8-9am) and then were immediately subjected to the UCMS protocol, as described
previously.192
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Stress Marker Analysis
Coat Score
Throughout the 8-week protocol, coat scores were recorded every week for all rodents,
with 0 being clean and 1 being dirty, for eight different body parts (i.e. head, neck, forelimbs,
stomach, hindlimbs, tail, genitals). A total cumulative coat score was determined across all parts,
and weight was recorded each week along with grooming habits.

Circulating Cortisol
A commercially available ELISA Kit (Cayman Chemical, Item #501320) was used to
examine corticosterone levels in duplicate accordingly to the manufacture’s instruction. Blood
samples were collected at the time of the terminal surgery and plasma was used for the ELISA
Kit.

Pancreas Health Analysis
Immunohistochemistry (IHC) Protocol
Pancreatic tissue was sectioned by cryo-stating (Leica CM3050S cryostat) three tissue
samples per slide and 5 slides per animal. The cryo-stat was kept as close to -23°C as possible
throughout the procedure, and the thickness was set to 8µm. These slides were then stored in a
freezer at -18°C.
Sectioned slides with pancreatic tissue were air-dried for 5-10 minutes before the IHC
process occurred. Once the slides were dried, the pap-pen was used to draw thin but solid lines
around each tissue section, and the slides were then rehydrated in 1X PBS 10 minutes. The slides
were fixed in room temperature, 4% paraformaldehyde for 20 minutes. Three, five-minute
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washes were done in 1X PBS before the slides were permeabilized using 0.2% Triton X-100 at
4°C. After 10 minutes, the slides were again washed in 1X PBS for three, 5-minute rounds. After
the third wash, the pap pen lines were carefully dried with Kimwipes and blocked with 150µL
horse serum and 10mL 1X PBS for 60 minutes. The pap pen lines were re-dried after the 60minute blocking period, and the primary Insulin (C27C9) Rabbit mAb #3014 antibody and
primary Glucagon (10988) Mouse mAb solution was incubated on slides in a damp box at 4°C
overnight.
On the second day of the IHC protocol, the slides were washed three times in 1X PBS.
After the final wash, the lights were turned off and remained off for the remainder of the protocol
due to the use of photosensitive antibodies. Alexafluor 546 IgG anti-rabbit secondary (for
insulin) and Alexafluor 488 IgG, IgM anti-mouse (for glucagon) was incubated on the slides for
45 minutes. The slides were then washed in PBS three times for10 minutes each round. Using
Kimwipes, the slides were dried as much as possible without disturbing the sections and were
mounted with DAPI hard set/DAPI prolonged stain and a cover. The slides were stored in the
dark at room temperature overnight. The slides were imaged using SPOT5.2 Advanced program,
and the images were analyzed using ImageJ.

Protein Analysis
Protein Quantification
Homogenates were made up by combining 200µL of RIPA buffer (with added dissolved
protease-inhibitor tablet) for every 1mL of pancreatic tissue into a tube with ceramic beads, and
using the BeadMill system, the tubes were homogenized for 30 seconds at a speed of 4m/s.
Homogenates were centrifuged for 10 minutes at 4°C at a speed of 10rpm, and the supernatant
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was pipetted into fresh tubes and saved, while the rest was discarded. Standards were prepared
for the DC assay (Bio-Rad, Hercules, California). Homogenates were diluted with doubledistilled water at a 1:20 ratio, and samples and standards were pipetted, in duplicate fashion, into
a 96-well plate. A mixture of 20µL of reagent S per every 1mL of reagent A was made, and
25µL of this mixture was pipetted into each well except the blanks in wells H1-H2. 200µL of
reagent B was added to each well, except the blanks in wells H1-H2, and the plate was gently
shaken for 30 seconds and incubated for 15 minutes before begin read at 750nm.
TXNIP Analysis
To prepare the Simple Western System Wes plate (Protein Simpleâ, San Jose,
California), DDT powder was mixed with 40µL of DIY water, and Master Mix tube powder was
mixed with 20µL DDT mix and 20µL 10X Sample Buffer. The Biotinylated ladder was made by
adding 20µL of double-distilled water to the ladder powder. Samples were diluted with 0.1X
sample buffer to equate 3µL of protein per sample. After these were made, 4µL of diluted lysate
and 1µL of Master Mix were mixed in fresh tubes. After all the samples were made up in Master
Mix, they were heat denatured at 95°C for 5 minutes. The samples were added after they had
been allowed to cool to room temperature. The primary TXNIP (TG2596699, Invitrogenâ)
Rabbit IgG mAb and TXNIP (188865, abcamâ) Rabbit IgG mAb were diluted to a 1:50 ratio.
The secondary conjugate (anti-Rabbit, (Protein Simpleâ, San Jose, California) was diluted 10fold, and 200µL of Luminal-S was added to 200µL of Peroxide to yield the Luminol-Peroxide
mix added to the fifth row of the plate.
The plate was centrifuged for 5 minutes at room temperature at 1000g or 2500rpm. The
Wash Buffer was added to the top three rows. The bottom foil was then removed after centrifuge,
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and any bubbles that had formed in the plate were popped using pipette tips or the foil before the
plate was run.
Before running the Wes plate, a Self-Test was run on the Wes System. The plate and
capillaries were then loaded, and the assay tab was set to the correct setting for the plate size
being ran. The stacking time was changed to 18 minutes, the separation time to 31 minutes, and
the antibody times all to 30 minutes, after which the plate was run.

Cytokine Analysis
RayBiotech® (Peachtree Corners, GA) kits were used for all ELISAs (IL-4, IL-6, IL-10,
IL-1b, and TNF-a). A DC assay was done before the ELISA kits were started to get the protein
concentrations. Wash Buffer (20X) was diluted to a 1X Wash Buffer, the Sample Diluent Buffer
and the Assay Diluent Buffer were diluted 5-fold. Standards were made according to each
different cytokine ELISA based on the manufacturer’s instructions.
100µL of the standards and samples were added in duplicate to the wells. The plate was
covered and incubated for 2.5 hours at room temperature with gentle shaking. The plate was
washed four times by filling the wells with 300µL 1X Wash Buffer. The wells were completely
dried by carefully vacuuming out all the remaining liquid. The biotinylated ladder was made by
adding 100µL of Assay Diluent Buffer to the Detection Antibody, and the detection antibody
concentrate was then diluted 80-fold. 100µL of the 1X biotinylated ladder was added to every
well and incubated, covered for 1 hour at room temperature with gentle shaking. The washing
step was then repeated, and all remaining liquid was removed from all the wells. HPRStreptavidin concentrate was made for each ELISA as follows:
o IL-4: 600-fold dilution with 1X Assay Diluent Buffer
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o IL-6: 400-fold dilution with 1X Assay Diluent Buffer
o IL-10: 140-fold dilution with 1X Assay Diluent Buffer
o IL-1b: 200-fold dilution with 1X Assay Diluent Buffer
o TNF-a: 200-fold dilution with Assay Diluent Buffer
Each HPR-Streptavidin concentrate was made into 10mL stocks, and 100µL was pipetted into
each well and incubated, covered at room temperature with gentle shaking for 45 minutes. The
wash step was repeated, and all the liquid was vacuumed out of the wells. With the lights
dimmed 100µL of the One-Step Substrate Reagent was added to each well, and the plate was
covered and incubated in the dark at room temperature with gentle shaking for 30 minutes. 50µL
of Stop Solution was added to the wells, and the plate was read immediately at 450nm.

Cell Death Analysis
TUNEL staining was performed using a Cell Death Detection ELISAPLUS (Rocheâ
Indianapolis, IN). Slides were sectioned with 8µm thick pancreas tissue and stored in -20°C
freezer. After air-drying for 10-15 minutes, sections were tightly traced with the pap-pen. Slides
were fixed in 4% paraformaldehyde for 10 minutes, after which three, five-minute washes were
done with 1X PBS. Slides were dried and permeabilized in 0.1X Triton-X-100 for two minutes.
Slides were washed twice for ten minutes in 1X PBS. Slides were dried, and TUNEL solution
was made using an In Situ Cell Death Detection Kit, Fluorescein. 450µL of labeling solution was
added to 50µL of enzyme solution. 50µL of this mixture was added to ten sections, and 50µL of
labeling solution alone was added to two sections for negative controls. Slides were incubated
again and placed in a humidifier at 37°C, or body temperature, for 60 minutes. A final tenminute wash was done after the TUNEL incubation in 1X PBS. The dried slides were mounted
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with DAPI hard set/DAPI prolonged stain and a cover slip. The slides were stored in the dark at
room temperature overnight.
Pancreatic lysate homogenates were used in the PierceÔ BCA Protein Assay Kit
(ThermoFisher Scientific, Waltham, MA) to obtain protein concentration values for all samples.
Samples were diluted to a 1:20 ratio with double-distilled water, and 10µL of standard and 10µL
of sample were added to each well in two 96-well plates in a duplicate fashion. Working reagent
was made by thoroughly mixing 50 parts of BCA Reagent A with 1 part BCA Reagent B, and
200µL of the working reagent was added to each well, expect the duplicate blank wells. The
plate was shaken for 30 seconds and left to incubate for 30minutes in 37°C. After the plate was
cooled to room temperature, the absorbance was measured at 562nm on a plate reader.
The same homogenates were used from the BCA Protein Assay for the Cell Death
ELISAPLUS kit (Rocheâ Indianapolis, IN). 20µL of samples were randomly plated in duplicate in
a pre-coated 96-well Cell Death ELISA plate, along with a positive control provided by the Cell
Death kit and one blank well. All samples were carefully pipetted into the center of the plate. To
each well, 80µL of the Immunoreagent was added. The Microplate (MP) was covered in an
adhesive cover and incubated for 2hours, shaking at 300rpm at 25°C. The MP was washed three
times by filling and emptying the wells with 250-300µL of incubation buffer. The wells were
dried completely, and 100µL of ABTS solution was added. The plate incubated for
approximately 15 minutes with shaking at 250rpm. 100µL of Stop Solution was pipetted into the
wells, and the absorbance was measured at 405nm in a plate reader.
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Oxidative Stress Analysis
Hydrogen Peroxide Analysis
Pancreatic lysate homogenates were used for a DC Assay prior to the AmplexÒ Red Kit
(Invitrogenâ) , as described above. 10mM Amplexâ Red reagent stock solution was made
dissolving Amplexâ Red reagent vial contents in 60µL of DMSO, and 1X Reaction Buffer was
made by adding 4mL of 5X Reaction Buffer to 16mL of deionized water. 10U/mL of
Horseradish Peroxidase (HRP) was made by dissolving the contents of the HRP vial in 1.0mL of
1X Reaction Buffer. 20mM Hydrogen Peroxidase (H2O2) working solution was made by diluting
22.7µL of ~3% H2O2 into 977µL of 1X Reaction Buffer. Standards were prepared in a serial
dilution from 2.5µM to 0.02µM using the 20mM H2O2 working solution.
50µL of the standards were pipetted in duplicate into the first two columns of wells, and
50µL of sample were pipetted in duplicate in random order in the rest of the wells. This was
done over two plates, with five samples from plate one being added to five single wells on plate
two for cross-plate comparisons. An Amplexâ Red reagent/HRP working solution was made by
combining 50µL of 10mM Amplexâ Red reagent stock solution, 100µL of 10U/mL HRP stock
solution, and 4.85mL of 1X Reaction Buffer. 50µL of this Amplexâ Red reagent/HRP working
solution was added to each well, and the plate was incubated at room temperature for 30 minutes,
protected from the light. A microplate reader equipped for excitation in the range of 530-560nm
was used to read the plate after incubation.

Nitrate/Nitrite Analysis
The Sievers Nitric Oxide Analyzer (NOA 280) was used for Nitrate Analysis. Samples
approximately 50µg in size were homogenized using RIPA buffer with protease inhibitors to
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give volumes of approximately 100µg. Standards were made using 1/10 dilutions starting with
100mM NO3- of stock solution sodium nitrate (0.425g NaNO3- / 50mL H20). The standards were
made as follows: 10mM, 1mM, 100µM, 10µM, 1µM, and 0.1µM. Figure 5 shows the set up for
the NOA 208.
50µL injections were done for standards and samples. After samples were taken up in the
syringe, the needle was wiped with a kimwipe and then injected into the needle valve. After
injections, the syringe was cleaned with distilled water two to three times, and the needle was
wiped with a kimwipe. The standards and samples were injected after baseline was attained after
each injection. Samples were tested in a triplicate manner, and standards were retested
throughout the experiment to make sure no changes were occurring in the NOA 208
environment.
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Figure 5 shows the set-up of the Sievers Nitric Oxide Analyzer (NOA 280) was used for Nitrate
Analysis.193

Superoxide/Uric Acid Analysis
Homogenates from above DC Protein Assays were used. Stock solutions were prepared
and the concentrations of the standards was determined using the spectrophotometer. These
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concentrations were used to determine the dilutions of the stock solutions. The water bath was
set to 37°C, and three tubes were labeled for each sample, with duplicates for each tube (i.e. six
total tubes for each sample).
The samples were columned through G-25 columns. One tube collected the volume liquid
that eludes from the column before the Blue-Dextran colored solution (pre-column). A second
tube collected the blue stained solution (post-column). The meniscus were marked on each of
these tubes to use as a reference to other samples collected in fresh tubes. BCA protein assays
were ran before and after columning to obtain protein concentrations for a ratio pre-column to
post-column to determine the dilution factor due to columning.
After Xanthine was added to the samples, the tubes were vortexed and incubated in a
37°C water bath for 60 minutes. During the incubation, 150µL solution of Allopurinol in
Acetonitrile (ACN) was made. At the 55 minute mark of the incubation, the tubes were placed in
the same order as the addition of Xanthine, and at the 60 minute mark, 1mL of ice cold
ACN/Allopurinol solution was added in the same order as Xanthine addition. The samples were
vortexed and centrifuged at 4°C at 12,600rpm for 15 minutes. The supernatant was transferred to
the second set of pre-labeled tubes and store at -80°C until time of analysis.
At the time of analysis by HPLC-EC, the samples were speed-dried and resolubilized in
300µL of mobile phase. The uric acid standards were prepared and both standards and samples
were ran as prepared.

Statistical Analysis
All data are expressed as means and ± standard errors. A multifactorial (analysis of
variance (ANOVA) with an interaction term was performed to determine differences between
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groups using SPSS program. Tukey’s post hoc analysis was performed to compare between
groups. Independent T-tests were used to compare differences between two groups when
appropriate. Statistical significance was set to P £ 0.05.
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CHAPTER 4: RESULTS
Treadmill running for eight weeks significantly decreased body mass in both genotypes
(LZR and OZR). In addition, UCMS alone significantly decreased body mass in both LZR and
OZR. UCMS significantly increased glucose, corticosterone, and coat scores levels in LZR and
OZR, which demonstrated that the UCMS protocol was successful in producing a stress response
in the rats (Table 1). EX rodents had significantly lower glucose levels when compared to C and
EXS animals. Insulin plasma levels were significantly lower with training and increased with
UCMS in LZR. This data is shown in Table 1.

Table 1 *P<0.05 vs. control group within same strain, ‡P<0.05 vs. UCMS group within strain,
§P<0.05 vs. Training group.
LZRLZROZROZRLZR-C
LZR-S
OZR-S
EX
EXS
C
EX
Age
(weeks)
18
18
18
18
18
18
18
Body Mass
400 ±
358 ±
361 ±
343 ±
641 ±
599 ±
585 ±
20
15*
12*
12*
29
27*
20*
(g)
Glucose

OZREXS
18
567 ±
25

98 ± 15

101 ±
20‡

124 ±
17*

115 ±
15

184 ±
29

154 ±
29*‡

230 ±
34*

219 ±
37*§

1.2 ±
0.5

1.4 ± 0.7

2.1 ±
1.0

1.8 ±
1.0

6.6 ±
2.7

4.6 ±
2.4*

7.8 ±
3.7*

6.2 ±
2.4

6.97 ±
0.4

9.44 ±
2.6

8.78 ±
1.3*

10.6 ±
2.4*

17.3 ±
3.6*

15.78 ±
3.6§

(mg dl-1)
Insulin
(ng ml-1)
Corticosterone

10.67 ± 13.82 ±
3.6*
1.4

The effects of obesity on pancreatic morphology
Pancreatic b-cell numbers (p=0.03), a-cell numbers (p=0.00), and islet area (p=0.01)
were significantly higher in OZR-C versus LZR-C (Figure 6A, C, and E), while b-cell to a-cell
ratio (p=0.07) was trending higher in LZR-C versus OZR-C (Figure 6F). b-cell density was
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decreased (p=0.02), while a-cell density was increased (p=0.05) in OZR-C compared to LZR-C
(Figure 6 B and D).

d

d

Figure 6 LZR-C vs. OZR-C mean b-cell number (A), b-cell density (B), a-cell number (C), acell density (D), islet area (E), and b-cell to a-cell ratio (F). dp<0.05 vs LZR-C.
The effects of stress alone and in combination with obesity on pancreatic morphology
There were no significant differences in b-cell numbers, a-cell numbers, islet area, or bcell to a-cell ratio in LZR-S versus LZR-C (Figure 7A, C, and E). Although b-cell density was
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not significantly changed, a-cell density was increased (p=0.01) in LZR-S compared to LZR-C
(Figure 7B and D). OZR-S had a significantly lower number of a-cells (p=0.00) compared to
OZR-C (Figure 8C), but there were no significant differences in b-cell numbers, islet area, or bcell to a-cell ratio in OZR-S versus OZR-C (Figure 8A, C, and E). b-cell and a-cell densities
were not different in OZR-S versus OZR-C (Figure 8B and D).

*

Figure 7 LZR-C vs. OZR-S mean b-cell number (A), density (B), a-cell number (C), a-cell
density (D), islet area (E), and b-cell to a-cell ratio (F). *p<0.05 vs. control group within same
strain.
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Figure 8 OZR-C vs. OZR-S mean b-cell number (A), b-cell density (B), a-cell number (C), acell density (D), islet area (E), and b-cell to a-cell ratio (F). *p<0.05 vs. control group within
same strain.
The effects of exercise training on obesity and stress related changes to pancreatic
morphology
There was no significant difference in pancreatic b-cell number, but b-cell density was
trending to increase (p=0.10) between OZR-EX and OZR-C (Figure 9A-B). The a-cell number
(p=0.00) was lower and the islet area (p=0.02) was smaller in OZR-EX compared to OZR-C
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(Figure 9C and E). The a-cell density did not significantly change between these groups (Figure
9D). In addition, the b-cell to a-cell ratio was significantly higher (p=0.04) in OZR-EX versus

P=0.

OZR-C (Figure 9F).

Figure 9 OZR-C vs. OZR-EX mean b-cell number (A), b-cell density (B), a-cell number (C),
a-cell density (D), islet area (E), and b-cell to a-cell ratio (F). *p<0.05 vs. control group within
same strain.
In the UCMS model, b-cell number (p=0.00), a-cell number (p=0.00), and islet area (p=0.00)
were significantly higher in LZR-EXS compared to LZR-S, but there were no significant
changes in b-cell or a-cell density or b-cell to a-cell ratio (Figure10A-F).
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Figure 10 LZR-S vs. LZR-EXS mean b-cell number (A), b-cell density (B), a-cell number
(C), a-cell density (D), islet area (E), and b-cell to a-cell ratio (F). ‡p<0.05 vs. UCMS group
within strain.
Pancreatic b-cell number and density, a-cell number and density, islet area, and b-cell to a-cell
ratio did not show significant differences in OZR-EXS versus OZR-S (Figure 11A-F). All of the
data from the above results on pancreatic b-cell number, a-cell number, islet area, and b-cell to
a-cell ratio is also shown in Table 2.
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Figure 11 OZR-S vs. OZR-EXS mean b-cell number (A), b-cell density (B), a-cell number
(C), a-cell density (D), islet area (E), and b-cell to a-cell ratio (F). ‡p<0.05 vs. UCMS group
within strain.
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Table 2 *P<0.05 vs. control group within same strain, ‡P<0.05 vs. UCMS group within strain

LZR- LZRC
Ex

LZRS

LZRExS

66 ± 9
45 ± 7

147 ±
11‡
88 ± 6

2.3 ±
0.72

1.8 ±
0.11

1.5 ±
0.16

61746
± 7409

129770
± 10463

157002
± 19128

123 ±

b-Cell
96 ± 9
10*
a-Cell
49 ± 4 55 ± 4
b-Cell to
a-Cell
2.4 ±
2.3 ±
Ratio
0.31
0.14
Islet
94167 106783
Area
± 8708 ± 9479

OZRC

OZREx

OZRS

OZRExS

127 ±
16
51 ± 6

111 ±
9
36 ± 5

5.4 ±
1.2

2.7 ±
0.33

4.5 ±
0.96

91687 ±
15615

121704
± 17613

106769
± 9240

134 ± 15 146 ± 22
98 ± 15
35 ± 5

The effects of obesity on the pancreatic pro-inflammatory environment and level of apoptosis
TXNIP was trending higher (p=0.10) in pancreatic tissue of the OZR-C compared to the
LZR-C (Figure 12A). As expected, TNF-a concentration was higher (p=0.03) in OZR-C versus
LZR-C (Figure 12B), however, although IL-1b appeared greater in OZR-C compared to LZR-C,
the difference was not significant (Figure 12C). IL-4 concentration was higher (p=0.01) in OZRC versus LZR-C, but IL-10 and IL-6 showed no significant differences between groups, although
IL-10 (p=0.08) did show a trending increase (Figure 12D-F). Hydrogen peroxide was shown to
decrease in OZR-C compared to LZR-C (p=0.00), but other markers of oxidative stress were not
significantly different (Figure 13A-C). No differences were noted in the level of apoptosis
between groups.
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Figure 12 LZR-C vs. OZR-C mean TXNIP (A), TNF-a (B), IL-1b (C), IL-4 (D), IL-6 (E), IL10 (F) concentration. dp<0.05 vs LZR-C.

Figure 13 LZR-C vs. OZR-C Nitrate/nitrite, NO (A), hydrogen peroxide, H2O2 (B), and
superoxide, XO (C). *p<0.05
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The effects of stress alone and in combination with obesity on the pancreatic proinflammatory environment and level of apoptosis
Stress, alone (LZR-S) and in combination with obesity (OZR-S), did not cause a
significant increase in TXNIP when compared with matched controls (Figure 14A and 16A). No
cytokines, including TNF-a, IL-1b, IL-4, IL-5, and IL10, were significantly different in LZR-S
compared to LZR-C (Figure 14B-F). In OZR-S, TNFa (p=0.03), IL-4 (p=0.02), and IL-6
(p=0.01) concentrations were lower when compared to OZR-C (Figure 16B, D, and F). IL-1b
and IL-10 concentrations were not different in OZR-S compared to OZR-C (Figure 16C and E).
Hydrogen peroxide was decreased in LZR-S and OZR-S when compared to their respective
controls (p=0.00), although no other markers of oxidative stress were not significantly different
between these groups. (Figure 15 and 17A-C). No changes in apoptosis were seen between any
of these groups.

Figure 14 LZR-C vs. LZR-S mean TXNIP (A), TNF-a (B), IL-1b (C), IL-4 (D), IL-6 (E), IL10 (F) concentration. *p<0.05 vs control group within same strain.
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Figure 15 LZR-C vs. LZR-S Nitrate/nitrite, NO (A), hydrogen peroxide, H2O2 (B), and
superoxide, XO (C). *p<0.05

Figure 16 OZR-C vs. OZR-S mean TXNIP (A), TNF-a (B), IL-1b (C), IL-4 (D), IL-6 (E), IL10 (F) concentration. *p<0.05 vs control group within same strain.
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Figure 17 OZR-C vs. OZR-S Nitrate/nitrite, NO (A), hydrogen peroxide, H2O2 (B), and
superoxide, XO (C). *p<0.05
The effects of exercise training on the obesity and stress related changes to the pancreatic proinflammatory environment and level of apoptosis
TXNIP was not significantly different in OZR-EX versus OZR-C (Figure 18A). IL-4
(p=0.03) and IL-6 (p=0.03) were significantly lower (Figure 18D and F), while IL-10 (p=0.06)
and TNF-a (p=0.07) were trending lower in OZR-EX compared to OZR-C (Figure 18B and E).
IL-1b concentration was not significantly different between these two groups (Figure 18C).
Although hydrogen peroxide was shown to be lower in OZR-EX versus OZR-C (p=0.00), no
other markers of oxidative stress were different (Figure 19A-C).
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Figure 18 OZR-C vs. OZR-EX mean TXNIP (A), TNF-a (B), IL-1b (C), IL-4 (D), IL-6 (E),
IL-10 (F) concentration. *p<0.05 vs control group within same strain.

Figure 19 LZR-C vs. LZR-S Nitrate/nitrite, NO (A), hydrogen peroxide, H2O2 (B), and
superoxide, XO (C). *p<0.05
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TXNIP (p=0.01) was significantly lower in LZR-EXS compared to LZR-S (Figure 20A), but no
significant differences were seen in the proinflammatory cytokines TNF-a, IL-1b, IL-4, IL-6, or
IL-10 concentrations between LZR-EXS and LZR-S (Figure 20B-F). Nitrate/nitrite activity was
lower, and hydrogen peroxide was higher in LZR-EXS compared to LZR-S (p=0.02), while
superoxide was not different (Figure 21A-C).The mean TXNIP in OZR-EXS tended to be lower
(p=0.10) compared with OZR-S (Figure 22A). TNF-a, IL-1b, IL-4, IL-6, and IL-10
concentrations were not significantly different in OZR-EXS versus OZR-S (Figure 22B-F).
Nitrate/Nitrite activity was lower in OZR-EXS versus OZR-S (p=0.02), although no other
oxidative stress measures saw significant differences (Figure 23A-C). No apoptosis was see with
any exercise groups.

Figure 20 LZR-S vs. LZR-EXS mean TXNIP (A), TNF-a (B), IL-1b (C), IL-4 (D), IL-6 (E),
IL-10 (F) concentration. ‡p<0.05 vs. UCMS group within strain.
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Figure 21 LZR-C vs. LZR-S Nitrate/nitrite, NO (A), hydrogen peroxide, H2O2 (B), and
superoxide, XO (C). ‡p<0.05

Figure 22 OZR-S vs. OZR-EXS mean TXNIP (A), TNF-a (B), IL-1b (C), IL-4 (D), IL-6 (E),
IL-10 (F) concentration. ‡p<0.05 vs. UCMS group within strain.
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Figure 23 LZR-C vs. LZR-S Nitrate/nitrite, NO (A), hydrogen peroxide, H2O2 (B), and
superoxide, XO (C). ‡p<0.05
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CHAPTER 5: DISCUSSION
The primary purpose of this study was to determine the effects of obesity, chronic stress
and exercise training on pancreatic morphology and health. We hypothesized that obesity would
decrease the number of pancreatic b-cells, the b-cell to a-cell ratio, and islet area. A primary
finding of this study was that obesity did not result in an decrease in b-cell number but instead
was associated with increases in b-cell number, a-cell number, and islet area. With pancreatic bcell and a-cell numbers increasing, this lead to no change in the b-cell to a-cell ratio. Islet area
may have increased to compensate for increases in both b-cell and a-cell numbers, and did so at
a greater magnitude as indicated by the lower b-cell density in the obese animals. Previous
research has shown that there are five stages to developing insulin resistance: compensation,
stable adaptation, unstable early decompensation, stable decompensation, and severe
decompensation.42 Given that pancreatic b-cell numbers were higher with obesity in this study, it
can be suggested that the obese animals were in an early compensation stage of insulin
resistance. This is further supported by the fact that plasma insulin was higher in the obese
animals. The insulin producing pancreatic b-cells may have been undergoing hyperplasia to
control for the higher levels of glucose also seen in the obese animals. Although the glucose
measurement, 184 mg dl-1 could suggest that the rats were further along than the compensation
phase, this was not a fasted measurement and was only taken at the time of the termination
surgery. In order to compensate for increases in b- and a-cell numbers, islet area also increased
in the obese animals. Previous research has suggested that obesity leads to a reduced b-cell to acell ratio due to b-cell apoptosis with no real change to a-cell numbers.40 However, this would
most likely occur during later phases of decomposition, when the pancreatic b-cells begin
experiencing elevated apoptosis and greater sustained fasted glucose levels than observed in the
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present study.40,42 Our results showed very little apoptosis in the obese animals and no
differences compared with controls again indicating an earlier stage of decompensation.
Although these results differ from those of Shimabukuro et al 89 who reported that apoptosis
occurred during the early stages of diabetes development in obese homozygous (fa/fa) male
ZDF, they are consistent with those found that in human pancreas from obese individuals during
autopsies.93 In the latter study, b-cell mass was actually increased with obesity.93
We also hypothesized that chronic stress would negatively alter the morphology of the
pancreas. However, no significant differences were observed between stress and controlled rats
in the number of b- and a-cells, islet area, or the b-cell to a-cell ratio. The a-cell density did
increase in the lean stress environment, which can be a result of the small decrease seen in islet
area, though that decrease was not significant. We further hypothesized that stress in
combination with obesity would have a combined deleterious effect on the pancreatic b-cell and
a-cell numbers, islet area, and b-cell to a-cell ratio. However, the combined effect only had a
deleterious effect on the a-cell numbers. The fact that obesity and chronic stress had little
negative effects on pancreatic morphology was further confirmed by the absence of pancreatic
apoptosis in each of these conditions. Plasma insulin levels at the time of surgery were higher in
the stressed, obese animals, again suggesting that b-cells were still able to compensate for the
elevated glucose plasma levels that were seen in the stressed, obese animals. Altogether this can
suggest that these animals were in the early compensation phase of the pathway to insulin
resistance.42
Chronic stress which leads to elevated levels of GCs can result in damage to the pancreas
that can lead to insulin resistance, hyperinsulinemia, and hyperglycemia.5,9,98,109 Humans
subjected to chronic GC treatment (>14 days) showed decreases in insulin secretion when
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subjected to a glucose challenge. This impairment in insulin action could suggest an indirect loss
in pancreatic b-cell function or suppression of the release of insulin by pancreatic b-cells.110,111
Rats exposed to eight weeks of UCSM did in fact, have significantly elevated corticosteroid and
glucose levels. However, the UCMS protocol used in the current study produced very few
morphological changes to the pancreas and was not associated with a loss of β-cells. These
results go against the belief that GCs cause metabolic and morphological attenuations to the
pancreatic b-cells.20,112 It is possible that the level of stress used in the current study was too low
to produce the morphological changes to the pancreas often seen in other models. The stress
method used by Zhou et al155 that resulted in increases in TXNIP within the hippocampus and
frontal cortex with stress, utilized a much more intense protocol, including foot shock, tail clamp,
and cold water swimming. Give that our UCMS model was a mild stress model, this may suggest
that a longer duration is required to see these negative effects at the level of the pancreas.
Chronic exercise has been shown to improve physical attributes of health, including
reduced blood pressure, enhanced cardiovascular fitness, increased insulin sensitivity, reduced
abdominal adiposity, and prevention of chronic diseases, such as obesity.157,158 We hypothesized
that the addition of eight weeks of treadmill running would attenuate obesity-related changes in
b-cell numbers, the b-cell to a-cell ratio, and islet area. Exercise training in the obese animals
was associated with decreases in a-cell numbers and islet area, but increases in b-cell to a-cell
ratio. Eight weeks of treadmill running was associated with lower body weights in both obese
and lean animals compared with controls. This was associated with slightly lower glucose and
corticosterone levels, both of which are known to stimulate β-cell proliferation and islet growth.
It is possible that many of the deleterious physiological effects associated with obesity were
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blunted in the trained rats, which provided less stress on the pancreas leading to reduced cell and
islet proliferation.
It was also hypothesized that eight weeks of treadmill running would attenuate the stressrelated morphological changes to the pancreas. The UCSM protocol used in this study, shown to
be effective by increased coat scores in the stress animals, produced only a few measured
morphological changes to pancreas even when combined with obesity. However, when
combined with exercise, stressed animals had greater numbers of β- and α-cells and a larger islet
area when compared with the stressed only rats. This effect may represent either a reversal of the
minor stress-induced decreases to the pancreas (e.g., smaller islet area) or more likely, a greater
stimulation for pancreatic growth. Although exercise training has been shown to reduce stress,
the model used in the current study required animals to be stimulated to run.169,172,173 Animals,
which simultaneously underwent the UCMS protocol, may have been conditioned to perceive the
treadmill running as an additional stressor. The UCSM protocol induces stress that presents
similar behaviors to that of depression in rodents, presenting itself such that rodents show
anhedonia-like behavior and other behaviors that suggest depression is present.112,146,148
Although HPA-axis activity decreased in rats exposed to low-intensity stressors with six-weeks
of intermittent, voluntary wheel running, forced treadmill running when combined with the
UCMS may have caused greater levels of corticosteroid release and a greater stimulation of
pancreatic growth.170,171 Interesting, corticosteroid was slightly higher in the LZR-EXS
compared with the LZR-EX rats, supporting this idea.
Obesity and chronic stress have been shown to result in a proinflammatory environment
within the host.7,17,99,117,130,131 TXNIP is a proapoptotic protein associated with increased
oxidative stress and apoptosis, specifically b-cell apoptosis within the pancreas.24,25,185
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According to previous research, obesity and chronic stress are associated with increases in
TXNIP throughout different parts of the body.155,184,185,187,188,189 Based on this research, we
hypothesized that TXNIP would increase with obesity in the pancreas, and our findings indicated
that TXNIP was elevated, although not significantly, in the obese versus lean rats. We also
hypothesized that obesity would be associated with an increased proinflammatory environment.
Our results showed that the proinflammatory cytokine TNF-a was significantly elevated in the
obese animals, although IL-1β was not. Previous research has suggested that both TNF-a and IL1b increase in conjunction with obesity. 7,10,22,27,28 IL-1b did appear to be somewhat elevated
with obesity in the present study, but this elevation did not reach significance compared with
controls. IL-1b is a proinflammatory cytokine, primarily produced by the NLPR3
inflammasome and triggered by TXNIP.22,27,189,190 Since we did not see a significant increase in
TXNIP, it can be suggested that IL-1b would also not be significantly increased. IL-4, a
cytokine that can act acutely as an anti-inflammatory cytokine and chronically as a
proinflammatory cytokine, was increased with obesity; IL-4 works to increase macrophage
activation to combat foreign substances, but IL-4 can chronically stimulate inflammation.194 IL6, a cytokine acting as either anti-inflammatory or proinflammatory depending on the tissue of
origin, was not effected by obesity.13,67,68,69 Finally, IL-10 concentrations, an anti-inflammatory
cytokine, had an increasing trend in the obese animals.13,70 These results may suggest that there
was an increase in the proinflammatory environment of the obese animals, and that an antiinflammatory response was reacting to reduce this inflammation. Obesity has been shown to
induce a phenotypic change in macrophage polarization, from M2 to M1.13,65 During this shift, it
would be reasonable to see both proinflammatory and anti-inflammatory cytokines upregulated
as the environment is shifting from M1 to M2.
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We hypothesized that eight weeks of UCMS alone and in combination with obesity
would increase pancreatic TXNIP, proinflammatory cytokines, and apoptosis and decrease antiinflammatory cytokines. TXNIP was not shown to be increased in the pancreas by either chronic
stress alone, or in combination with obesity. The fact that we did not see a difference in TXNIP
between the LZR-S and LZR-C indicates that the UCMS protocol alone was either not stressful
enough or too short to produce an effect within the pancreas. Previous research has reported that
rodents that experienced chronic stress had significantly elevated TXNIP expression in the
hypothalamus and frontal cortex when compared to control mice. It was proposed that increases
in corticosterone due to stress lead to these increases in TXNIP and its downstream regulators.155
A study done with INS1 b-cells and human and mouse pancreatic islets demonstrated that
treatment with glucocorticosteroids led to increases in TXNIP expression, and that expression
was even more pronounced than in hyperglycemic conditions.187 Although circulating
corticosteroid and glucose were higher in the LZR-S versus LZR-C animals, these values may
not have reached the level necessary to cause an elevation in pancreatic TXNIP in the stressed
animals. Furthermore, no cytokines, including TNF-a, IL-1b, IL-4, IL-6, and IL10, were
changed with chronic stress alone. These results were further confirmed when comparing OZR-S
to OZR-C. In combination with obesity, TNF-a, IL-4, and IL-6 were actually decreased in the
obese stressed rats, while IL-10 and IL-1b were not changed. These results were highly
surprising and seem to indicate a unique interaction between the two treatments. It must be
noted that the cytokines were measured within the pancreas lysates. Future research should
examine the level of stress necessary to see changes to the proinflammatory environment within
the pancreas independent of other conditions.
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Although we hypothesized that eight weeks of treadmill running would decrease TXNIP,
proinflammatory cytokines concentrations, and indices of apoptosis in combination with obesity,
our results showed that TXNIP and IL-1b was not different between OZR-EX and OZR-C.
However, obese animals which underwent eight weeks of treadmill running did have lower TNFa, IL-4 and IL-6, cytokines that can be proinflammatory, and lowering trends in IL-10 , an antiinflammatory cytokine.13,56,70 When combined with the fact that treadmill running was associated
with reduced α-cell numbers and smaller islet, this seems to indicate that our exercise training
was sufficient to limit some of the deleterious effects of obesity. Brunn et al showed that 15
weeks of hypocaloric diet and daily exercise resulted in decreases in circulating proinflammatory
cytokines and decreases in adipose tissue expression of inflammatory markers, like IL-6 and
TNF-a.163 Given our exercise protocol was only eight weeks, it is promising to see that there are
already lowering cytokine levels.
Treadmill running in combination with chronic stress was hypothesized to attenuate the
stress-induced increases in TXNIP, proinflammatory cytokines, and apoptosis. However, as
previously mentioned, stress alone produced very few negative effects within the pancreas.
When combined with treadmill running, only TXNIP was lower in LZR-EXS compared with
LZR-S animals. No differences were seen with any cytokine concentrations, including TNF-a,
IL-1b, IL-4, IL-6, or IL-10. It is interesting that no differences were observed in the
proinflammatory environment between those animals who underwent eight weeks of UCMC and
treadmill running verses UCMS alone. These results do seem to go along with our findings that
the combined treatment caused enhanced pancreatic growth. We speculate that the latter was
caused by a combination of the stimulatory effects of enhanced circulating glucocorticoids and
possibly glucose, and a pancreatic environment conducive to growth. Associated with this idea
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was the fact that TXNIP was lowered in the combined group. This would have led to a reduced
environment for apoptosis, possibly allowing β cells to proliferate and islets to grow. The fact
that the oxidative stress marker H2O2 was higher in LZR-EXS animals may indicate that the
combined treatment was more stimulatory to the pancreas. However, these results must be taken
with caution as oxidative stress was measured on frozen not fresh tissue.
We further hypothesized that eight weeks of treadmill running would attenuate the
combined effects of obesity and UCMS on pancreatic increases in TXNIP, proinflammatory
cytokines, and apoptosis and decreases in anti-inflammatory cytokines. TXNIP concentration did
show a decreasing trend with exercise, although there were no differences in any of the
cytokines, including TNF-a, IL-1b, IL-4, IL-6, and IL-10. This would again indicate that the
UCSM protocol used in the present student may have been ineffective in causing negative
changes within the pancreas.
The stress-induced increases in TXNIP in the hippocampus and frontal cortex in mice,
was associated with increases in corticosterone, a key regulator of TXNIP.155 Corticosterone
followed the TXNIP pattern in the current study, increasing with obesity and decreasing with
exercise training. UCMS also increased corticosterone significantly in both genotypes although
TXNIP was not significantly increased with chronic stress. This again would indicate that
obesity, more so than the UCMS used in the current study, was able to alter specific hormones
and proteins know to have an effect on pancreatic morphology and health.
Although TXNIP, a proapoptotic protein, was increased in some incidences in this study,
there were no signs of apoptosis, as confirmed through multiple methods. This could suggest that
downstream markers of this proapoptotic pathway, such as p-ASK-1, were not yet activated in
the cascade to cell death.
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CONCLUSION
In conclusion, in a model of obesity and metabolic syndrome, the pancreas appeared to be
stimulated to grow as indicated by greater numbers of β- and α-cells and larger islets even in the
presence of slightly higher pancreatic TXNIP and TNF-α. Since apoptosis was not observed, it
can be suggested that the proapoptotic-TXNIP pathway in the pancreas may take more time than
we allotted to reach a true proapoptotic phase. Eight weeks of treadmill exercise training was
shown to attenuate some of the obesity-induced morphological and proinflammatory changes
within the pancreas. It did not however appear to reduce TXNIP. Eight weeks of UCMS alone
produced no morphological changes in the pancreas, no alterations in TXNIP, and no changes in
the measured proinflammatory cytokines compared with controls. When combined with obesity,
we also very few deleterious effects within the pancreas. Exercise training did appear to lower
TXNIP in both lean and obese stressed mice. It would appear from this study that a greater stress
load or a longer period of stress is necessary to show detrimental effects within the pancreas.

LIMITATIONS AND FUTURE RESEARCH
A limitation to this study is that data was collected at s a single time-point in the
progression of the chronic stress and obesity protocol. When forming a hypothesis, it is
impossible to know at what point in the progression of pancreatic health decline the animals may
be. Future research should examine the longitudinal effects of both obesity and stress. Another
limitation to this study is that pancreatic lysates were made of the whole pancreas tissue
homogenates. Although we had desired to isolate the b-cells and mitochondria of the b-cells,
these procedures could not be done on previously frozen tissue. Results for many of the
measured oxidative stress markers were quite surprising and opposite to what has been reported
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in the literature. A major limitation to this data was the fact that these measures were made on
frozen not fresh tissue, the preferred method for this analysis. Unfortunately, fresh tissue was
unavailable and having only samples from a previous study limits experiments that require fresh
tissue. Lastly, it would benefit this study to have more animals, as some of the groups only had 3
or 4 pancreases available.
Future research can be done to evaluate the training relationship with TXNIP and the
thioredoxin system. A longevity study can be done to assess at what point pancreatic health
(along with other organs) begins to decline and b-cell numbers begin to change and the role that
TXNIP and its downstream agonists play in the development of insulin resistance with this
model. Using a model, such as Zucker Fatty Diabetic (ZDF) rat, would be better to assess the
effects of TXNIP, given that this model is known to develop pancreatic b-cell dysfunction and
apoptosis. Using the ZDF model in a longevity study,

could provide a better understanding of

TXNIP’s relationship with b-cell apoptosis and how high feeding, chronic stress fat, and exercise
influence outcomes. A TXNIP knockout or overexpressed mouse could be used to better
understand the role of TXNIP in apoptosis in the pancreas and other organs and how chronic
stress and training influence these effects, though this would be more useful after studies were
done with the ZDF rats. These proteins and relationships can also be studied on other organs.
Skeletal muscle expression of TXNIP levels and other downstream markers of the TXNIP
pathway can be measured to assess if training is changing the periphery environment in a model
of metabolic syndrome and chronic stress.
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